Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
Recruiting · NCT06835387 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors | small intestine adenocarcinoma | Recruiting | Phase 2 | 2026-07-28 | NCT06835387 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
| Ipsen | 59 |
| Tiago Biachi de Castria | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atlantic Health System | Morristown | United States | 17 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Parkview Research Center | Fort Wayne | United States | 17 |
| University of Illinois Cancer Center | Chicago | United States | 34 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |
| Virginia Commonwealth University | Richmond | United States | 156 |
| Washington University School of Medicine | St Louis | United States | 895 |